What are the appropriate dosing regimens for doxycycline and amoxicillin‑clavulanate (Augmentin) in patients undergoing intermittent hemodialysis?

Hemodialysis Dosing for Doxycycline and Augmentin

Neither doxycycline nor amoxicillin-clavulanate (Augmentin) require dose adjustment for patients on intermittent hemodialysis, and both should be administered after dialysis sessions.

Doxycycline Dosing

Doxycycline requires no dose modification in hemodialysis patients. The standard dose of 100 mg twice daily (or appropriate indication-specific dosing) can be continued without adjustment 1.

Key Pharmacokinetic Rationale:

• Hemodialysis does not alter the serum half-life of doxycycline (18-22 hours remains unchanged) 1
• Only 1-5% of doxycycline is excreted renally in patients with severe renal insufficiency (creatinine clearance <10 mL/min) 1
• The drug is not significantly removed by dialysis due to high protein binding and extensive tissue distribution 1

Timing consideration: While not explicitly required, administering doxycycline after dialysis sessions is reasonable to avoid any theoretical minimal drug loss and facilitate adherence.

Augmentin (Amoxicillin-Clavulanate) Dosing

Augmentin dosing in hemodialysis patients depends on infection severity but generally requires supplemental dosing after dialysis sessions.

Standard Dosing Approach:

For most infections:

• Give 500/125 mg (amoxicillin/clavulanate) after each dialysis session (typically 3 times weekly)
• Alternatively, 250-500 mg daily dosing can be used for less severe infections

For severe infections requiring higher doses:

• 875/125 mg after each dialysis session may be appropriate
• The dose should be administered immediately post-dialysis

Key Pharmacokinetic Rationale:

• Both amoxicillin and clavulanic acid are significantly removed by hemodialysis 2
• Clavulanic acid has a higher extraction ratio (0.74) compared to amoxicillin (0.44), meaning it is removed more efficiently during dialysis 2
• Serum concentrations are substantially lower on dialysis days versus non-dialysis days 2
• Recent data confirms that oral administration of 500/125 mg amoxicillin/clavulanate 30-120 minutes prior to hemodialysis maintains adequate prophylactic plasma concentrations throughout the dialysis period 3

Critical Timing Consideration:

Administer Augmentin immediately after hemodialysis to:

1. Replace drug removed during dialysis
2. Ensure adequate drug levels until the next dialysis session
3. Facilitate directly observed therapy adherence

Important Clinical Caveats

For Both Medications:

Monitor for accumulation: While doxycycline doesn't accumulate, both components of Augmentin may accumulate between dialysis sessions in anuric patients 2. Watch for:

• Gastrointestinal side effects (diarrhea, nausea)
• Signs of drug toxicity
• Hepatotoxicity (particularly with amoxicillin-clavulanate)

Interdialytic interval matters: Patients dialyzing 3 times weekly have longer interdialytic intervals on weekends (approximately 72 hours vs. 48 hours), which may affect drug accumulation, particularly for Augmentin.

Residual renal function: If the patient has significant residual kidney function (urine output >200 mL/day), standard dosing may be more appropriate than the reduced hemodialysis regimen.

Common Pitfall to Avoid:

Do not use the FDA-labeled renal dosing adjustments for creatinine clearance <30 mL/min for hemodialysis patients. These recommendations are for patients with severe CKD who are NOT on dialysis. Hemodialysis patients require post-dialysis supplementation due to drug removal during the procedure 4, 5.

Special Consideration for Augmentin Formulations:

The various Augmentin formulations (200/28.5 mg per 5 mL, 400/57 mg per 5 mL, and ES-600 with 600/42.9 mg per 5 mL) contain different amounts of clavulanic acid and are not interchangeable 6. Ensure the correct formulation is prescribed based on the dosing strategy chosen.